New search | Conferencedetail
mail
Print view
 
 

4th Tumor Myeloid Targeting Therapies Summit 2024

Evvnt Promotion / evvnt
Archive
-
11.06.2024 - 13.06.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Conference themes
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/2219781-3?pid=4832

Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
 

Enquiries and Registration:

https://go.evvnt.com/2219781-2?pid=4832
Mr. Luke Kelly
 
Categories
Oncology
Languages
English
Congress fees
USD 2199.00 - USD 5097.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

newTreeÄrzte der WeltÄrztekammer für WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHilfswerk AustriaÖsterreichische Gesellschaft für Public HealthÖsterreichische Akademie der ÄrzteCenter of Excellence